Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

PURPOSE: This paper is aimed at comparing the short-term efficacy of the combination of docetaxel, oxaliplatin, and capecitabine (DOX) with the combination of oxaliplatin and capecitabine (XELOX) as neoadjuvant chemotherapy regimens for the treatment of patients with resectable gastric or gastroesop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuan, Zhao, Qun, Li, Yong, Fan, Liqiao, Zhang, Zhidong, Zhao, Xuefeng, Tan, Bibo, Wang, Dong, Yang, Peigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324337/
https://www.ncbi.nlm.nih.gov/pubmed/34335737
http://dx.doi.org/10.1155/2021/5590626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324337/
https://www.ncbi.nlm.nih.gov/pubmed/34335737
http://dx.doi.org/10.1155/2021/5590626

Ejemplares similares